‘Global Artificial Intelligence in Healthcare Market By Component (Hardware, Software, Service, By Technology (Querying Method, Natural Language Processing, Context Aware Processing, Speech Recognition, Decision Management, Others (Biometrics, AI Modeling, Etc.)), By Application (Robot assisted Surgery, Virtual Nursing Assistants, Administrative Workflow Assistance, Fraud Detection, Connected Machines, Clinical Trails, Preliminary Diagnosis, Others (Dosage Error Reduction, Cybersecurity, Etc.), By End Users (Healthcare Providers, Pharmaceutical & Biotechnology Company, Patient, Payer), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027’
Industry Trends:
Artificial intelligence is being significantly used for a range of healthcare & research purposes which finely consists of disease detection, healthcare delivery services, drug discovery and chronic condition management. It has been reported that as the geriatric population is increasing in some economies (such as the United Kingdom), the need for better access and quality of care is necessary for population aged over 100. Thus, the adoption of virtual health coaches & nurses along with AI- based clinical services for diagnosing illnesses at home is expected to proliferate the healthcare industry.
IBM Watson Care Manager System matches individuals with a care provider that meets their needs and is within their allocated care budget. The company aims to design individual care plans and offers insights for more effective use of care management resources. Alder Hey Children’s Hospital based in Liverpool is working with IBM Watson to create a “cognitive hospital”. This will include an app that will facilitate interactions with patients. This application usage is designed for identifying patient anxieties before a visit and helping clinicians to deliver proper treatment services to the targeted individuals.
AI is used to identify and analyze patterns faster and precisely in large complex datasets. The Institute of Cancer Research’s canSAR database duly combines clinical & genetic data from patients with information derived from scientific research. They use artificial intelligence technology to make predictions about the new discoveries about the cancer drugs. The development of “Eve”, an AI robot scientist by researchers enables the drug discovery processes to be both faster and economical in nature. The possible use of AI in clinical care includes medical imaging, echocardiography, screening for neurological conditions and surgery. Taking echocardiography as an instance, the Ultromics system, trialed at John Radcliffe Hospital used AI application for analyzing echocardiography scans, mainly for detecting heartbeat patterns and diagnose coronary heart disease. Robotic AI tools were used to carry out specific tasks in keyhole surgery that included tying knots to close wounds.
Global artificial intelligence in healthcare market is expanding at a CAGR of 48.29 % over the forecast period. The study analyzes the market in terms of revenue, production and sales volume across all the major markets.
North America Artificial Intelligence in Healthcare Market Sales, 2019 - 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of global artificial intelligence in healthcare market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global artificial intelligence in healthcare market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
Market participants include Bay Labs, Inc, CloudMedx Inc., Enclitic, General Electric, General Vision, Google Inc., IBM Corporation, iCarbonX, Intel Corporation, Koninklijke Philips, maxQ, Microsoft, Next IT Corp., Nvidia Corporation, Siemens Healthcare GmbH, Welltok amongst others
By Component
- Hardware
- Software
- Service
By Technology
- Querying Method
- Natural Language Processing
- Context Aware Processing
- Speech Recognition
- Decision Management
- Others (Biometrics, AI Modeling, Etc.)
By Application
- Robot assisted Surgery
- Virtual Nursing Assistants
- Administrative Workflow Assistance
- Fraud Detection, Connected Machines
- Clinical Trails
- Preliminary Diagnosis
- Others (Dosage Error Reduction, Cybersecurity, Etc.),
By End Users
- Healthcare Providers
- Pharmaceutical & Biotechnology Company
- Patient
- Payer
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2013 - 2017
1.2.2. Base Year: 2018
1.2.3. Forecast Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Country-Wise Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Artificial Intelligence in Healthcare
Market
6. Market Synopsis:
Artificial Intelligence in Healthcare Market
7. Artificial Intelligence in Healthcare Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Artificial Intelligence in Healthcare Market
7.4. Market Determinants Radar Chart
7.5.
Porter’s Five Force
Analysis
7.6. SWOT Analysis
8. Global Artificial Intelligence in Medicine Market Analysis
and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts
8.2. Global Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
8.2.1. Hardware
8.2.1.1. Definition
8.2.1.2. Market Penetration, 2018
8.2.1.3. Market Estimation, 2013 – 2018
8.2.1.4. Market Forecast, 2019 – 2027
8.2.1.5. Compound Annual Growth Rate (CAGR)
8.2.1.6. Regional Bifurcation
8.2.1.6.1. North America
8.2.1.6.1.1. Market Estimation, 2013 – 2018
8.2.1.6.1.2. Market Forecast, 2019 – 2027
8.2.1.6.2. Europe
8.2.1.6.2.1. Market Estimation, 2013 – 2018
8.2.1.6.2.2. Market Forecast, 2019 – 2027
8.2.1.6.3. Asia Pacific
8.2.1.6.3.1. Market Estimation, 2013 – 2018
8.2.1.6.3.2. Market Forecast, 2019 – 2027
8.2.1.6.4. Middle East and Africa
8.2.1.6.4.1. Market Estimation, 2013 – 2018
8.2.1.6.4.2. Market Forecast, 2019 – 2027
8.2.1.6.5. Latin America
8.2.1.6.5.1. Market Estimation, 2013 – 2018
8.2.1.6.5.2. Market Forecast, 2019 – 2027
8.2.2. Software
8.2.2.1. Definition
8.2.2.2. Market Penetration, 2018
8.2.2.3. Market Estimation, 2013 – 2018
8.2.2.4. Market Forecast, 2019 – 2027
8.2.2.5. Compound Annual Growth Rate (CAGR)
8.2.2.6. Regional Bifurcation
8.2.2.6.1. North America
8.2.2.6.1.1. Market Estimation, 2013 – 2018
8.2.2.6.1.2. Market Forecast, 2019 – 2027
8.2.2.6.2. Europe
8.2.2.6.2.1. Market Estimation, 2013 – 2018
8.2.2.6.2.2. Market Forecast, 2019 – 2027
8.2.2.6.3. Asia Pacific
8.2.2.6.3.1. Market Estimation, 2013 – 2018
8.2.2.6.3.2. Market Forecast, 2019 – 2027
8.2.2.6.4. Middle East and Africa
8.2.2.6.4.1. Market Estimation, 2013 – 2018
8.2.2.6.4.2. Market Forecast, 2019 – 2027
8.2.2.6.5. Latin America
8.2.2.6.5.1. Market Estimation, 2013 – 2018
8.2.2.6.5.2. Market Forecast, 2019 – 2027
8.2.3. Service
8.2.3.1. Definition
8.2.3.2. Market Penetration, 2018
8.2.3.3. Market Estimation, 2013 – 2018
8.2.3.4. Market Forecast, 2019 – 2027
8.2.3.5. Compound Annual Growth Rate (CAGR)
8.2.3.6. Regional Bifurcation
8.2.3.6.1. North America
8.2.3.6.1.1. Market Estimation, 2013 – 2018
8.2.3.6.1.2. Market Forecast, 2019 – 2027
8.2.3.6.2. Europe
8.2.3.6.2.1. Market Estimation, 2013 – 2018
8.2.3.6.2.2. Market Forecast, 2019 – 2027
8.2.3.6.3. Asia Pacific
8.2.3.6.3.1. Market Estimation, 2013 – 2018
8.2.3.6.3.2. Market Forecast, 2019 – 2027
8.2.3.6.4. Middle East and Africa
8.2.3.6.4.1. Market Estimation, 2013 – 2018
8.2.3.6.4.2. Market Forecast, 2019 – 2027
8.2.3.6.5. Latin America
8.2.3.6.5.1. Market Estimation, 2013 – 2018
8.2.3.6.5.2. Market Forecast, 2019 – 2027
8.3. Key Segment for Channeling Investments
8.3.1. By Component
9. Global Artificial Intelligence in Medicine Market Analysis
and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
9.2.1. Querying Method
9.2.1.1. Definition
9.2.1.2. Market Penetration, 2018
9.2.1.3. Market Estimation, 2013 – 2018
9.2.1.4. Market Forecast, 2019 – 2027
9.2.1.5. Compound Annual Growth Rate (CAGR)
9.2.1.6. Regional Bifurcation
9.2.1.6.1. North America
9.2.1.6.1.1. Market Estimation, 2013 – 2018
9.2.1.6.1.2. Market Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1. Market Estimation, 2013 – 2018
9.2.1.6.2.2. Market Forecast, 2019 – 2027
9.2.1.6.3. Asia Pacific
9.2.1.6.3.1. Market Estimation, 2013 – 2018
9.2.1.6.3.2. Market Forecast, 2019 – 2027
9.2.1.6.4. Middle East and Africa
9.2.1.6.4.1. Market Estimation, 2013 – 2018
9.2.1.6.4.2. Market Forecast, 2019 – 2027
9.2.1.6.5. Latin America
9.2.1.6.5.1. Market Estimation, 2013 – 2018
9.2.1.6.5.2. Market Forecast, 2019 – 2027
9.2.2. Natural Language Processing
9.2.2.1.
Definition
9.2.2.2. Market Penetration, 2018
9.2.2.3. Market Estimation, 2013 – 2018
9.2.2.4. Market Forecast, 2019 – 2027
9.2.2.5. Compound Annual Growth Rate (CAGR)
9.2.2.6. Regional Bifurcation
9.2.2.6.1. North America
9.2.2.6.1.1. Market Estimation, 2013 – 2018
9.2.2.6.1.2. Market Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1. Market Estimation, 2013 – 2018
9.2.2.6.2.2. Market Forecast, 2019 – 2027
9.2.2.6.3. Asia Pacific
9.2.2.6.3.1. Market Estimation, 2013 – 2018
9.2.2.6.3.2. Market Forecast, 2019 – 2027
9.2.2.6.4. Middle East and Africa
9.2.2.6.4.1. Market Estimation, 2013 – 2018
9.2.2.6.4.2. Market Forecast, 2019 – 2027
9.2.2.6.5. Latin America
9.2.2.6.5.1. Market Estimation, 2013 – 2018
9.2.2.6.5.2. Market Forecast, 2019 – 2027
9.2.3. Context Aware Processing
9.2.3.1.
Definition
9.2.3.2. Market Penetration, 2018
9.2.3.3. Market Estimation, 2013 – 2018
9.2.3.4. Market Forecast, 2019 – 2027
9.2.3.5. Compound Annual Growth Rate (CAGR)
9.2.3.6. Regional Bifurcation
9.2.3.6.1. North America
9.2.3.6.1.1. Market Estimation, 2013 – 2018
9.2.3.6.1.2. Market Forecast, 2019 – 2027
9.2.3.6.2. Europe
9.2.3.6.2.1. Market Estimation, 2013 – 2018
9.2.3.6.2.2. Market Forecast, 2019 – 2027
9.2.3.6.3. Asia Pacific
9.2.3.6.3.1. Market Estimation, 2013 – 2018
9.2.3.6.3.2. Market Forecast, 2019 – 2027
9.2.3.6.4. Middle East and Africa
9.2.3.6.4.1. Market Estimation, 2013 – 2018
9.2.3.6.4.2. Market Forecast, 2019 – 2027
9.2.3.6.5. Latin America
9.2.3.6.5.1. Market Estimation, 2013 – 2018
9.2.3.6.5.2. Market Forecast, 2019 – 2027
9.2.4. Speech Recognition
9.2.4.1. Definition
9.2.4.2. Market Penetration, 2018
9.2.4.3. Market Estimation, 2013 – 2018
9.2.4.4. Market Forecast, 2019 – 2027
9.2.4.5. Compound Annual Growth Rate (CAGR)
9.2.4.6. Regional Bifurcation
9.2.4.6.1. North America
9.2.4.6.1.1. Market Estimation, 2013 – 2018
9.2.4.6.1.2. Market Forecast, 2019 – 2027
9.2.4.6.2. Europe
9.2.4.6.2.1. Market Estimation, 2013 – 2018
9.2.4.6.2.2. Market Forecast, 2019 – 2027
9.2.4.6.3. Asia Pacific
9.2.4.6.3.1. Market Estimation, 2013 – 2018
9.2.4.6.3.2. Market Forecast, 2019 – 2027
9.2.4.6.4. Middle East and Africa
9.2.4.6.4.1. Market Estimation, 2013 – 2018
9.2.4.6.4.2. Market Forecast, 2019 – 2027
9.2.4.6.5. Latin America
9.2.4.6.5.1. Market Estimation, 2013 – 2018
9.2.4.6.5.2. Market Forecast, 2019 – 2027
9.2.5. Decision Management
9.2.5.1. Definition
9.2.5.2. Market Penetration, 2018
9.2.5.3. Market Estimation, 2013 – 2018
9.2.5.4. Market Forecast, 2019 – 2027
9.2.5.5. Compound Annual Growth Rate (CAGR)
9.2.5.6. Regional Bifurcation
9.2.5.6.1. North America
9.2.5.6.1.1. Market Estimation, 2013 – 2018
9.2.5.6.1.2. Market Forecast, 2019 – 2027
9.2.5.6.2. Europe
9.2.5.6.2.1. Market Estimation, 2013 – 2018
9.2.5.6.2.2. Market Forecast, 2019 – 2027
9.2.5.6.3. Asia Pacific
9.2.5.6.3.1. Market Estimation, 2013 – 2018
9.2.5.6.3.2. Market Forecast, 2019 – 2027
9.2.5.6.4. Middle East and Africa
9.2.5.6.4.1. Market Estimation, 2013 – 2018
9.2.5.6.4.2. Market Forecast, 2019 – 2027
9.2.5.6.5. Latin America
9.2.5.6.5.1. Market Estimation, 2013 – 2018
9.2.5.6.5.2. Market Forecast, 2019 – 2027
9.2.6. Others (Biometrics, AI Modeling, Etc.)
9.2.6.1. Definition
9.2.6.2. Market Penetration, 2018
9.2.6.3. Market Estimation, 2013 – 2018
9.2.6.4. Market Forecast, 2019 – 2027
9.2.6.5. Compound Annual Growth Rate (CAGR)
9.2.6.6. Regional Bifurcation
9.2.6.6.1. North America
9.2.6.6.1.1. Market Estimation, 2013 – 2018
9.2.6.6.1.2. Market Forecast, 2019 – 2027
9.2.6.6.2. Europe
9.2.6.6.2.1. Market Estimation, 2013 – 2018
9.2.6.6.2.2. Market Forecast, 2019 – 2027
9.2.6.6.3. Asia Pacific
9.2.6.6.3.1. Market Estimation, 2013 – 2018
9.2.6.6.3.2. Market Forecast, 2019 – 2027
9.2.6.6.4. Middle East and Africa
9.2.6.6.4.1. Market Estimation, 2013 – 2018
9.2.6.6.4.2. Market Forecast, 2019 – 2027
9.2.6.6.5. Latin America
9.2.6.6.5.1. Market Estimation, 2013 – 2018
9.2.6.6.5.2. Market Forecast, 2019 – 2027
9.3. Key Segment for Channeling Investments
9.3.1. By Technology
10. Global Artificial Intelligence in Medicine Market Analysis
and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
10.2.1. Robot Assisted Surgery
10.2.1.1. Definition
10.2.1.2. Market Penetration, 2018
10.2.1.3. Market Estimation, 2013 – 2018
10.2.1.4. Market Forecast, 2019 – 2027
10.2.1.5. Compound Annual Growth Rate (CAGR)
10.2.1.6. Regional Bifurcation
10.2.1.6.1. North America
10.2.1.6.1.1. Market Estimation, 2013 – 2018
10.2.1.6.1.2. Market Forecast, 2019 – 2027
10.2.1.6.2. Europe
10.2.1.6.2.1.
Market Estimation, 2013 –
2018
10.2.1.6.2.2.
Market Forecast, 2019 –
2027
10.2.1.6.3. Asia Pacific
10.2.1.6.3.1.
Market Estimation, 2013 –
2018
10.2.1.6.3.2.
Market Forecast, 2019 –
2027
10.2.1.6.4. Middle East and Africa
10.2.1.6.4.1.
Market Estimation, 2013 –
2018
10.2.1.6.4.2.
Market Forecast, 2019 –
2027
10.2.1.6.5. Latin America
10.2.1.6.5.1.
Market Estimation, 2013 –
2018
10.2.1.6.5.2.
Market Forecast, 2019 –
2027
10.2.2. Virtual Nursing Assistants
10.2.2.1. Definition
10.2.2.2. Market Penetration, 2018
10.2.2.3. Market Estimation, 2013 – 2018
10.2.2.4. Market Forecast, 2019 – 2027
10.2.2.5. Compound Annual Growth Rate (CAGR)
10.2.2.6. Regional Bifurcation
10.2.2.6.1. North America
10.2.2.6.1.1.
Market Estimation, 2013 –
2018
10.2.2.6.1.2.
Market Forecast, 2019 –
2027
10.2.2.6.2. Europe
10.2.2.6.2.1.
Market Estimation, 2013 –
2018
10.2.2.6.2.2.
Market Forecast, 2019 –
2027
10.2.2.6.3. Asia Pacific
10.2.2.6.3.1.
Market Estimation, 2013 –
2018
10.2.2.6.3.2.
Market Forecast, 2019 –
2027
10.2.2.6.4. Middle East and Africa
10.2.2.6.4.1.
Market Estimation, 2013 –
2018
10.2.2.6.4.2.
Market Forecast, 2019 –
2027
10.2.2.6.5. Latin America
10.2.2.6.5.1.
Market Estimation, 2013 –
2018
10.2.2.6.5.2.
Market Forecast, 2019 –
2027
10.2.3. Administrative Workflow Assistance
10.2.3.1. Definition
10.2.3.2. Market Penetration, 2018
10.2.3.3. Market Estimation, 2013 – 2018
10.2.3.4. Market Forecast, 2019 – 2027
10.2.3.5. Compound Annual Growth Rate (CAGR)
10.2.3.6. Regional Bifurcation
10.2.3.6.1. North America
10.2.3.6.1.1.
Market Estimation, 2013 –
2018
10.2.3.6.1.2.
Market Forecast, 2019 –
2027
10.2.3.6.2. Europe
10.2.3.6.2.1.
Market Estimation, 2013 –
2018
10.2.3.6.2.2.
Market Forecast, 2019 –
2027
10.2.3.6.3. Asia Pacific
10.2.3.6.3.1.
Market Estimation, 2013 –
2018
10.2.3.6.3.2.
Market Forecast, 2019 –
2027
10.2.3.6.4. Middle East and Africa
10.2.3.6.4.1.
Market Estimation, 2013 –
2018
10.2.3.6.4.2.
Market Forecast, 2019 –
2027
10.2.3.6.5. Latin America
10.2.3.6.5.1.
Market Estimation, 2013 –
2018
10.2.3.6.5.2.
Market Forecast, 2019 –
2027
10.2.4. Fraud Detection
10.2.4.1. Definition
10.2.4.2. Market Penetration, 2018
10.2.4.3. Market Estimation, 2013 – 2018
10.2.4.4. Market Forecast, 2019 – 2027
10.2.4.5. Compound Annual Growth Rate (CAGR)
10.2.4.6. Regional Bifurcation
10.2.4.6.1. North America
10.2.4.6.1.1.
Market Estimation, 2013 –
2018
10.2.4.6.1.2.
Market Forecast, 2019 –
2027
10.2.4.6.2. Europe
10.2.4.6.2.1.
Market Estimation, 2013 –
2018
10.2.4.6.2.2.
Market Forecast, 2019 –
2027
10.2.4.6.3. Asia Pacific
10.2.4.6.3.1.
Market Estimation, 2013 –
2018
10.2.4.6.3.2.
Market Forecast, 2019 –
2027
10.2.4.6.4. Middle East and Africa
10.2.4.6.4.1.
Market Estimation, 2013 –
2018
10.2.4.6.4.2.
Market Forecast, 2019 –
2027
10.2.4.6.5. Latin America
10.2.4.6.5.1.
Market Estimation, 2013 –
2018
10.2.4.6.5.2.
Market Forecast, 2019 –
2027
10.2.5. Connected Machines
10.2.5.1. Definition
10.2.5.2. Market Penetration, 2018
10.2.5.3. Market Estimation, 2013 – 2018
10.2.5.4. Market Forecast, 2019 – 2027
10.2.5.5. Compound Annual Growth Rate (CAGR)
10.2.5.6. Regional Bifurcation
10.2.5.6.1. North America
10.2.5.6.1.1.
Market Estimation, 2013 –
2018
10.2.5.6.1.2.
Market Forecast, 2019 –
2027
10.2.5.6.2. Europe
10.2.5.6.2.1.
Market Estimation, 2013 –
2018
10.2.5.6.2.2.
Market Forecast, 2019 –
2027
10.2.5.6.3. Asia Pacific
10.2.5.6.3.1.
Market Estimation, 2013 –
2018
10.2.5.6.3.2.
Market Forecast, 2019 –
2027
10.2.5.6.4. Middle East and Africa
10.2.5.6.4.1.
Market Estimation, 2013 –
2018
10.2.5.6.4.2.
Market Forecast, 2019 –
2027
10.2.5.6.5. Latin America
10.2.5.6.5.1.
Market Estimation, 2013 –
2018
10.2.5.6.5.2.
Market Forecast, 2019 –
2027
10.2.6. Clinical Trial
10.2.6.1. Definition
10.2.6.2. Market Penetration, 2018
10.2.6.3. Market Estimation, 2013 – 2018
10.2.6.4. Market Forecast, 2019 – 2027
10.2.6.5. Compound Annual Growth Rate (CAGR)
10.2.6.6. Regional Bifurcation
10.2.6.6.1. North America
10.2.6.6.1.1.
Market Estimation, 2013 –
2018
10.2.6.6.1.2.
Market Forecast, 2019 –
2027
10.2.6.6.2. Europe
10.2.6.6.2.1.
Market Estimation, 2013 –
2018
10.2.6.6.2.2.
Market Forecast, 2019 –
2027
10.2.6.6.3. Asia Pacific
10.2.6.6.3.1.
Market Estimation, 2013 –
2018
10.2.6.6.3.2.
Market Forecast, 2019 –
2027
10.2.6.6.4. Middle East and Africa
10.2.6.6.4.1.
Market Estimation, 2013 –
2018
10.2.6.6.4.2.
Market Forecast, 2019 –
2027
10.2.6.6.5. Latin America
10.2.6.6.5.1.
Market Estimation, 2013 –
2018
10.2.6.6.5.2.
Market Forecast, 2019 –
2027
10.2.7. Preliminary Diagnosis
10.2.7.1. Definition
10.2.7.2. Market Penetration, 2018
10.2.7.3. Market Estimation, 2013 – 2018
10.2.7.4. Market Forecast, 2019 – 2027
10.2.7.5. Compound Annual Growth Rate (CAGR)
10.2.7.6. Regional Bifurcation
10.2.7.6.1. North America
10.2.7.6.1.1.
Market Estimation, 2013 –
2018
10.2.7.6.1.2.
Market Forecast, 2019 –
2027
10.2.7.6.2. Europe
10.2.7.6.2.1.
Market Estimation, 2013 –
2018
10.2.7.6.2.2.
Market Forecast, 2019 –
2027
10.2.7.6.3. Asia Pacific
10.2.7.6.3.1.
Market Estimation, 2013 – 2018
10.2.7.6.3.2.
Market Forecast, 2019 – 2027
10.2.7.6.4. Middle East and Africa
10.2.7.6.4.1.
Market Estimation, 2013 –
2018
10.2.7.6.4.2.
Market Forecast, 2019 –
2027
10.2.7.6.5. Latin America
10.2.7.6.5.1.
Market Estimation, 2013 –
2018
10.2.7.6.5.2.
Market Forecast, 2019 –
2027
10.2.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
10.2.8.1. Definition
10.2.8.2. Market Penetration, 2018
10.2.8.3. Market Estimation, 2013 – 2018
10.2.8.4. Market Forecast, 2019 – 2027
10.2.8.5. Compound Annual Growth Rate (CAGR)
10.2.8.6. Regional Bifurcation
10.2.8.6.1. North America
10.2.8.6.1.1.
Market Estimation, 2013 –
2018
10.2.8.6.1.2.
Market Forecast, 2019 –
2027
10.2.8.6.2. Europe
10.2.8.6.2.1.
Market Estimation, 2013 –
2018
10.2.8.6.2.2.
Market Forecast, 2019 –
2027
10.2.8.6.3. Asia Pacific
10.2.8.6.3.1.
Market Estimation, 2013 –
2018
10.2.8.6.3.2.
Market Forecast, 2019 –
2027
10.2.8.6.4. Middle East and Africa
10.2.8.6.4.1.
Market Estimation, 2013 –
2018
10.2.8.6.4.2.
Market Forecast, 2019 –
2027
10.2.8.6.5. Latin America
10.2.8.6.5.1.
Market Estimation, 2013 –
2018
10.2.8.6.5.2.
Market Forecast, 2019 –
2027
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Artificial Intelligence in Medicine Market Analysis
and Forecasts, 2019 – 2027
11.1. Overview
11.2. Global Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
11.2.1. Healthcare Providers
11.2.1.1. Definition
11.2.1.2. Market Penetration, 2018
11.2.1.3. Market Estimation, 2013 – 2018
11.2.1.4. Market Forecast, 2019 – 2027
11.2.1.5. Compound Annual Growth Rate (CAGR)
11.2.1.6. Regional Bifurcation
11.2.1.6.1. North America
11.2.1.6.1.1.
Market Estimation, 2013 –
2018
11.2.1.6.1.2.
Market Forecast, 2019 –
2027
11.2.1.6.2. Europe
11.2.1.6.2.1.
Market Estimation, 2013 –
2018
11.2.1.6.2.2.
Market Forecast, 2019 –
2027
11.2.1.6.3. Asia Pacific
11.2.1.6.3.1.
Market Estimation, 2013 –
2018
11.2.1.6.3.2.
Market Forecast, 2019 –
2027
11.2.1.6.4. Middle East and Africa
11.2.1.6.4.1.
Market Estimation, 2013 –
2018
11.2.1.6.4.2.
Market Forecast, 2019 –
2027
11.2.1.6.5. Latin America
11.2.1.6.5.1.
Market Estimation, 2013 –
2018
11.2.1.6.5.2.
Market Forecast, 2019 –
2027
11.2.2. Pharmaceutical & Biotechnology Company
11.2.2.1. Definition
11.2.2.2. Market Penetration, 2018
11.2.2.3. Market Estimation, 2013 – 2018
11.2.2.4. Market Forecast, 2019 – 2027
11.2.2.5. Compound Annual Growth Rate (CAGR)
11.2.2.6. Regional Bifurcation
11.2.2.6.1. North America
11.2.2.6.1.1.
Market Estimation, 2013 –
2018
11.2.2.6.1.2.
Market Forecast, 2019 –
2027
11.2.2.6.2. Europe
11.2.2.6.2.1.
Market Estimation, 2013 –
2018
11.2.2.6.2.2.
Market Forecast, 2019 –
2027
11.2.2.6.3. Asia Pacific
11.2.2.6.3.1.
Market Estimation, 2013 –
2018
11.2.2.6.3.2.
Market Forecast, 2019 –
2027
11.2.2.6.4. Middle East and Africa
11.2.2.6.4.1.
Market Estimation, 2013 –
2018
11.2.2.6.4.2.
Market Forecast, 2019 –
2027
11.2.2.6.5. Latin America
11.2.2.6.5.1.
Market Estimation, 2013 –
2018
11.2.2.6.5.2.
Market Forecast, 2019 –
2027
11.2.3. Patient
11.2.3.1. Definition
11.2.3.2. Market Penetration, 2018
11.2.3.3. Market Estimation, 2013 – 2018
11.2.3.4. Market Forecast, 2019 – 2027
11.2.3.5. Compound Annual Growth Rate (CAGR)
11.2.3.6. Regional Bifurcation
11.2.3.6.1. North America
11.2.3.6.1.1.
Market Estimation, 2013 –
2018
11.2.3.6.1.2.
Market Forecast, 2019 –
2027
11.2.3.6.2. Europe
11.2.3.6.2.1.
Market Estimation, 2013 –
2018
11.2.3.6.2.2.
Market Forecast, 2019 –
2027
11.2.3.6.3. Asia Pacific
11.2.3.6.3.1.
Market Estimation, 2013 –
2018
11.2.3.6.3.2.
Market Forecast, 2019 –
2027
11.2.3.6.4. Middle East and Africa
11.2.3.6.4.1.
Market Estimation, 2013 –
2018
11.2.3.6.4.2.
Market Forecast, 2019 –
2027
11.2.3.6.5. Latin America
11.2.3.6.5.1.
Market Estimation, 2013 –
2018
11.2.3.6.5.2.
Market Forecast, 2019 –
2027
11.2.4. Payer
11.2.4.1. Definition
11.2.4.2. Market Penetration, 2018
11.2.4.3. Market Estimation, 2013 – 2018
11.2.4.4. Market Forecast, 2019 – 2027
11.2.4.5. Compound Annual Growth Rate (CAGR)
11.2.4.6. Regional Bifurcation
11.2.4.6.1. North America
11.2.4.6.1.1.
Market Estimation, 2013 –
2018
11.2.4.6.1.2.
Market Forecast, 2019 –
2027
11.2.4.6.2. Europe
11.2.4.6.2.1.
Market Estimation, 2013 –
2018
11.2.4.6.2.2.
Market Forecast, 2019 –
2027
11.2.4.6.3. Asia Pacific
11.2.4.6.3.1.
Market Estimation, 2013 –
2018
11.2.4.6.3.2.
Market Forecast, 2019 –
2027
11.2.4.6.4. Middle East and Africa
11.2.4.6.4.1.
Market Estimation, 2013 –
2018
11.2.4.6.4.2.
Market Forecast, 2019 –
2027
11.2.4.6.5. Latin America
11.2.4.6.5.1.
Market Estimation, 2013 –
2018
11.2.4.6.5.2.
Market Forecast, 2019 –
2027
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Artificial Intelligence in Medicine Market
Analysis and Forecasts, 2019 – 2027
12.1. Overview
12.1.1. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn)
12.2. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
12.2.1. Hardware
12.2.2. Software
12.2.3. Service
12.3. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
12.3.1. Querying Method
12.3.2. Natural Language Processing
12.3.3. Context Aware Processing
12.3.4. Speech Recognition
12.3.5. Decision Management
12.3.6. Others (Biometrics, AI Modeling, Etc.)
12.4. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Robot Assisted Surgery
12.4.2. Virtual Nursing Assistants
12.4.3. Administrative Workflow Assistance
12.4.4. Fraud Detection
12.4.5. Connected Machines
12.4.6. Clinical Trial
12.4.7. Preliminary Diagnosis
12.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
12.5. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Healthcare Providers
12.5.2. Pharmaceutical & Biotechnology Company
12.5.3. Patient
12.5.4. Payer
12.6. North America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S.
12.6.1.1. U.S. Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
12.6.1.1.1. Hardware
12.6.1.1.2. Software
12.6.1.1.3. Service
12.6.1.2. U.S. Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
12.6.1.2.1. Querying Method
12.6.1.2.2. Natural Language Processing
12.6.1.2.3. Context Aware Processing
12.6.1.2.4. Speech Recognition
12.6.1.2.5. Decision Management
12.6.1.2.6. Others (Biometrics, AI Modeling, Etc.)
12.6.1.3. U.S. Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
12.6.1.3.1. Robot Assisted Surgery
12.6.1.3.2. Virtual Nursing Assistants
12.6.1.3.3. Administrative Workflow Assistance
12.6.1.3.4. Fraud Detection
12.6.1.3.5. Connected Machines
12.6.1.3.6. Clinical Trial
12.6.1.3.7. Preliminary Diagnosis
12.6.1.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
12.6.1.4. U.S. Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.1.4.1. Healthcare Providers
12.6.1.4.2. Pharmaceutical & Biotechnology Company
12.6.1.4.3. Patient
12.6.1.4.4.
Payer
12.6.2. Canada
12.6.2.1. Canada Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
12.6.2.1.1. Hardware
12.6.2.1.2. Software
12.6.2.1.3. Service
12.6.2.2. Canada Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
12.6.2.2.1. Querying Method
12.6.2.2.2. Natural Language Processing
12.6.2.2.3. Context Aware Processing
12.6.2.2.4. Speech Recognition
12.6.2.2.5. Decision Management
12.6.2.2.6. Others (Biometrics, AI Modeling, Etc.)
12.6.2.3. Canada Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
12.6.2.3.1. Robot Assisted Surgery
12.6.2.3.2. Virtual Nursing Assistants
12.6.2.3.3. Administrative Workflow Assistance
12.6.2.3.4. Fraud Detection
12.6.2.3.5. Connected Machines
12.6.2.3.6. Clinical Trial
12.6.2.3.7. Preliminary Diagnosis
12.6.2.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
12.6.2.4. Canada Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.2.4.1. Healthcare Providers
12.6.2.4.2. Pharmaceutical & Biotechnology Company
12.6.2.4.3. Patient
12.6.2.4.4.
Payer
12.6.3.1.
Mexico Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Component
12.6.3.1.1.
Hardware
12.6.3.1.2.
Software
12.6.3.1.3.
Service
12.6.3.2.
Mexico Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.3.2.1.
Querying Method
12.6.3.2.2.
Natural Language Processing
12.6.3.2.3.
Context Aware Processing
12.6.3.2.4.
Speech Recognition
12.6.3.2.5.
Decision Management
12.6.3.2.6.
Others (Biometrics, AI Modeling,
Etc.)
12.6.3.3.
Mexico Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1.
Robot Assisted Surgery
12.6.3.3.2.
Virtual Nursing Assistants
12.6.3.3.3.
Administrative Workflow
Assistance
12.6.3.3.4.
Fraud Detection
12.6.3.3.5.
Connected Machines
12.6.3.3.6.
Clinical Trial
12.6.3.3.7.
Preliminary Diagnosis
12.6.3.3.8.
Others (Dosage Error Reduction,
Cybersecurity, Etc.)
12.6.3.4.
Mexico Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1.
Healthcare Providers
12.6.3.4.2.
Pharmaceutical &
Biotechnology Company
12.6.3.4.3.
Patient
12.6.3.4.4.
Payer
12.6.4. Rest of North America
12.6.4.1. Rest of North America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Component
12.6.4.1.1. Hardware
12.6.4.1.2. Software
12.6.4.1.3. Service
12.6.4.2. Rest of North America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.4.2.1. Querying Method
12.6.4.2.2. Natural Language Processing
12.6.4.2.3. Context Aware Processing
12.6.4.2.4. Speech Recognition
12.6.4.2.5. Decision Management
12.6.4.2.6. Others (Biometrics, AI Modeling, Etc.)
12.6.4.3. Rest of North America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Robot Assisted Surgery
12.6.4.3.2. Virtual Nursing Assistants
12.6.4.3.3. Administrative Workflow Assistance
12.6.4.3.4. Fraud Detection
12.6.4.3.5. Connected Machines
12.6.4.3.6. Clinical Trial
12.6.4.3.7. Preliminary Diagnosis
12.6.4.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
12.6.4.4. Rest of North America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Healthcare Providers
12.6.4.4.2. Pharmaceutical & Biotechnology Company
12.6.4.4.3. Patient
12.6.4.4.4. Payer
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Component
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End Users
13. Europe Artificial Intelligence in Medicine Market Analysis
and Forecasts, 2019 – 2027
13.1. Overview
13.1.1. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn)
13.2. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
13.2.1. Hardware
13.2.2. Software
13.2.3. Service
13.3. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
13.3.1. Querying Method
13.3.2. Natural Language Processing
13.3.3. Context Aware Processing
13.3.4. Speech Recognition
13.3.5. Decision Management
13.3.6. Others (Biometrics, AI Modeling, Etc.)
13.4. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
13.4.1. Robot Assisted Surgery
13.4.2. Virtual Nursing Assistants
13.4.3. Administrative Workflow Assistance
13.4.4. Fraud Detection
13.4.5. Connected Machines
13.4.6. Clinical Trial
13.4.7. Preliminary Diagnosis
13.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.5. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.1. Healthcare Providers
13.5.2. Pharmaceutical & Biotechnology Company
13.5.3. Patient
13.5.4. Payer
13.6. Europe Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Country
13.6.1.1.
France Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Component
13.6.1.1.1.
Hardware
13.6.1.1.2.
Software
13.6.1.1.3.
Service
13.6.1.2.
France Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.1.2.1.
Querying Method
13.6.1.2.2.
Natural Language Processing
13.6.1.2.3.
Context Aware Processing
13.6.1.2.4.
Speech Recognition
13.6.1.2.5.
Decision Management
13.6.1.2.6.
Others (Biometrics, AI Modeling,
Etc.)
13.6.1.3.
France Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1.
Robot Assisted Surgery
13.6.1.3.2.
Virtual Nursing Assistants
13.6.1.3.3.
Administrative Workflow
Assistance
13.6.1.3.4.
Fraud Detection
13.6.1.3.5.
Connected Machines
13.6.1.3.6.
Clinical Trial
13.6.1.3.7.
Preliminary Diagnosis
13.6.1.3.8.
Others (Dosage Error Reduction,
Cybersecurity, Etc.)
13.6.1.4.
France Artificial Intelligence
in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1.
Healthcare Providers
13.6.1.4.2.
Pharmaceutical &
Biotechnology Company
13.6.1.4.3.
Patient
13.6.1.4.4.
Payer
13.6.2. The UK
13.6.2.1. The UK Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
13.6.2.1.1. Hardware
13.6.2.1.2. Software
13.6.2.1.3. Service
13.6.2.2. The UK Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
13.6.2.2.1. Querying Method
13.6.2.2.2. Natural Language Processing
13.6.2.2.3. Context Aware Processing
13.6.2.2.4. Speech Recognition
13.6.2.2.5. Decision Management
13.6.2.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.2.3. The UK Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
13.6.2.3.1. Robot Assisted Surgery
13.6.2.3.2. Virtual Nursing Assistants
13.6.2.3.3. Administrative Workflow Assistance
13.6.2.3.4. Fraud Detection
13.6.2.3.5. Connected Machines
13.6.2.3.6. Clinical Trial
13.6.2.3.7. Preliminary Diagnosis
13.6.2.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.2.4. The UK Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.2.4.1. Healthcare Providers
13.6.2.4.2. Pharmaceutical & Biotechnology Company
13.6.2.4.3. Patient
13.6.2.4.4. Payer
13.6.3. Spain
13.6.3.1. Spain Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
13.6.3.1.1. Hardware
13.6.3.1.2. Software
13.6.3.1.3. Service
13.6.3.2. Spain Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
13.6.3.2.1. Querying Method
13.6.3.2.2. Natural Language Processing
13.6.3.2.3. Context Aware Processing
13.6.3.2.4. Speech Recognition
13.6.3.2.5. Decision Management
13.6.3.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.3.3. Spain Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
13.6.3.3.1. Robot Assisted Surgery
13.6.3.3.2. Virtual Nursing Assistants
13.6.3.3.3. Administrative Workflow Assistance
13.6.3.3.4. Fraud Detection
13.6.3.3.5. Connected Machines
13.6.3.3.6. Clinical Trial
13.6.3.3.7. Preliminary Diagnosis
13.6.3.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.3.4. Spain Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.3.4.1. Healthcare Providers
13.6.3.4.2. Pharmaceutical & Biotechnology Company
13.6.3.4.3. Patient
13.6.3.4.4. Payer
13.6.4. Germany
13.6.4.1. Germany Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Component
13.6.4.1.1. Hardware
13.6.4.1.2. Software
13.6.4.1.3. Service
13.6.4.2. Germany Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Technology
13.6.4.2.1. Querying Method
13.6.4.2.2. Natural Language Processing
13.6.4.2.3. Context Aware Processing
13.6.4.2.4. Speech Recognition
13.6.4.2.5. Decision Management
13.6.4.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.4.3. Germany Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.4.3.1. Robot Assisted Surgery
13.6.4.3.2. Virtual Nursing Assistants
13.6.4.3.3. Administrative Workflow Assistance
13.6.4.3.4. Fraud Detection
13.6.4.3.5. Connected Machines
13.6.4.3.6. Clinical Trial
13.6.4.3.7. Preliminary Diagnosis
13.6.4.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.4.4. Germany Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Healthcare Providers
13.6.4.4.2. Pharmaceutical & Biotechnology Company
13.6.4.4.3. Patient
13.6.4.4.4. Payer
13.6.5. Italy
13.6.5.1. Italy Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
13.6.5.1.1. Hardware
13.6.5.1.2. Software
13.6.5.1.3. Service
13.6.5.2. Italy Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
13.6.5.2.1. Querying Method
13.6.5.2.2. Natural Language Processing
13.6.5.2.3. Context Aware Processing
13.6.5.2.4. Speech Recognition
13.6.5.2.5. Decision Management
13.6.5.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.5.3. Italy Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
13.6.5.3.1. Robot Assisted Surgery
13.6.5.3.2. Virtual Nursing Assistants
13.6.5.3.3. Administrative Workflow Assistance
13.6.5.3.4. Fraud Detection
13.6.5.3.5. Connected Machines
13.6.5.3.6. Clinical Trial
13.6.5.3.7. Preliminary Diagnosis
13.6.5.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.5.4. Italy Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.5.4.1. Healthcare Providers
13.6.5.4.2. Pharmaceutical & Biotechnology Company
13.6.5.4.3. Patient
13.6.5.4.4.
Payer
13.6.6. Nordic
13.6.6.1. Nordic Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
13.6.6.1.1. Hardware
13.6.6.1.2. Software
13.6.6.1.3. Service
13.6.6.2. Nordic Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
13.6.6.2.1. Querying Method
13.6.6.2.2. Natural Language Processing
13.6.6.2.3. Context Aware Processing
13.6.6.2.4. Speech Recognition
13.6.6.2.5. Decision Management
13.6.6.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.6.3. Nordic Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
13.6.6.3.1. Robot Assisted Surgery
13.6.6.3.2. Virtual Nursing Assistants
13.6.6.3.3. Administrative Workflow Assistance
13.6.6.3.4. Fraud Detection
13.6.6.3.5. Connected Machines
13.6.6.3.6. Clinical Trial
13.6.6.3.7. Preliminary Diagnosis
13.6.6.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.6.4. Nordic Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.6.4.1. Healthcare Providers
13.6.6.4.2. Pharmaceutical & Biotechnology Company
13.6.6.4.3. Patient
13.6.6.4.4.
Payer
13.6.6.5. Nordic Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1.
Sweden
13.6.6.5.2.
Norway
13.6.6.5.3.
Finland
13.6.6.5.4. Denmark
13.6.6.5.5. Iceland
13.6.6.5.6. Rest of
Nordic
13.6.7. The Benelux Union
13.6.7.1. The Benelux Union Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
13.6.7.1.1. Hardware
13.6.7.1.2. Software
13.6.7.1.3. Service
13.6.7.2. The Benelux Union Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
13.6.7.2.1. Querying Method
13.6.7.2.2. Natural Language Processing
13.6.7.2.3. Context Aware Processing
13.6.7.2.4. Speech Recognition
13.6.7.2.5. Decision Management
13.6.7.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.7.3. The Benelux Union Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1. Robot Assisted Surgery
13.6.7.3.2. Virtual Nursing Assistants
13.6.7.3.3. Administrative Workflow Assistance
13.6.7.3.4. Fraud Detection
13.6.7.3.5. Connected Machines
13.6.7.3.6. Clinical Trial
13.6.7.3.7. Preliminary Diagnosis
13.6.7.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.7.4. The Benelux Union Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Healthcare Providers
13.6.7.4.2. Pharmaceutical & Biotechnology Company
13.6.7.4.3. Patient
13.6.7.4.4.
Payer
13.6.7.5. The Benelux Union Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
13.6.8.1.1. Hardware
13.6.8.1.2. Software
13.6.8.1.3. Service
13.6.8.2. Rest of Europe Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
13.6.8.2.1. Querying Method
13.6.8.2.2. Natural Language Processing
13.6.8.2.3. Context Aware Processing
13.6.8.2.4. Speech Recognition
13.6.8.2.5. Decision Management
13.6.8.2.6. Others (Biometrics, AI Modeling, Etc.)
13.6.8.3. Rest of Europe Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1. Robot Assisted Surgery
13.6.8.3.2. Virtual Nursing Assistants
13.6.8.3.3. Administrative Workflow Assistance
13.6.8.3.4. Fraud Detection
13.6.8.3.5. Connected Machines
13.6.8.3.6. Clinical Trial
13.6.8.3.7. Preliminary Diagnosis
13.6.8.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
13.6.8.4. Rest of Europe Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Healthcare Providers
13.6.8.4.2. Pharmaceutical & Biotechnology Company
13.6.8.4.3. Patient
13.6.8.4.4. Payer
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Component
13.7.3. By Technology
13.7.4. By Application
13.7.5. By End Users
14. Asia Pacific Artificial Intelligence in Medicine Market
Analysis and Forecasts, 2019 – 2027
14.1. Overview
14.1.1. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn)
14.2. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
14.2.1. Hardware
14.2.2. Software
14.2.3. Service
14.3. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
14.3.1. Querying Method
14.3.2. Natural Language Processing
14.3.3. Context Aware Processing
14.3.4. Speech Recognition
14.3.5. Decision Management
14.3.6. Others (Biometrics, AI Modeling, Etc.)
14.4. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Robot Assisted Surgery
14.4.2. Virtual Nursing Assistants
14.4.3. Administrative Workflow Assistance
14.4.4. Fraud Detection
14.4.5. Connected Machines
14.4.6. Clinical Trial
14.4.7. Preliminary Diagnosis
14.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.5. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Healthcare Providers
14.5.2. Pharmaceutical & Biotechnology Company
14.5.3. Patient
14.5.4. Payer
14.6. Asia Pacific Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
14.6.1.1.1. Hardware
14.6.1.1.2. Software
14.6.1.1.3. Service
14.6.1.2. China Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
14.6.1.2.1. Querying Method
14.6.1.2.2. Natural Language Processing
14.6.1.2.3. Context Aware Processing
14.6.1.2.4. Speech Recognition
14.6.1.2.5. Decision Management
14.6.1.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.1.3. China Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
14.6.1.3.1. Robot Assisted Surgery
14.6.1.3.2. Virtual Nursing Assistants
14.6.1.3.3. Administrative Workflow Assistance
14.6.1.3.4. Fraud Detection
14.6.1.3.5. Connected Machines
14.6.1.3.6. Clinical Trial
14.6.1.3.7. Preliminary Diagnosis
14.6.1.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.1.4. China Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.1.4.1. Healthcare Providers
14.6.1.4.2. Pharmaceutical & Biotechnology Company
14.6.1.4.3. Patient
14.6.1.4.4. Payer
14.6.2. Japan
14.6.2.1. Japan Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
14.6.2.1.1. Hardware
14.6.2.1.2. Software
14.6.2.1.3. Service
14.6.2.2. Japan Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
14.6.2.2.1. Querying Method
14.6.2.2.2. Natural Language Processing
14.6.2.2.3. Context Aware Processing
14.6.2.2.4. Speech Recognition
14.6.2.2.5. Decision Management
14.6.2.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.2.3. Japan Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
14.6.2.3.1. Robot Assisted Surgery
14.6.2.3.2. Virtual Nursing Assistants
14.6.2.3.3. Administrative Workflow Assistance
14.6.2.3.4. Fraud Detection
14.6.2.3.5. Connected Machines
14.6.2.3.6. Clinical Trial
14.6.2.3.7. Preliminary Diagnosis
14.6.2.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.2.4. Japan Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.2.4.1. Healthcare Providers
14.6.2.4.2. Pharmaceutical & Biotechnology Company
14.6.2.4.3. Patient
14.6.2.4.4. Payer
14.6.3. India
14.6.3.1. India Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
14.6.3.1.1. Hardware
14.6.3.1.2. Software
14.6.3.1.3. Service
14.6.3.2. India Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
14.6.3.2.1. Querying Method
14.6.3.2.2. Natural Language Processing
14.6.3.2.3. Context Aware Processing
14.6.3.2.4. Speech Recognition
14.6.3.2.5. Decision Management
14.6.3.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.3.3. India Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
14.6.3.3.1. Robot Assisted Surgery
14.6.3.3.2. Virtual Nursing Assistants
14.6.3.3.3. Administrative Workflow Assistance
14.6.3.3.4. Fraud Detection
14.6.3.3.5. Connected Machines
14.6.3.3.6. Clinical Trial
14.6.3.3.7. Preliminary Diagnosis
14.6.3.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.3.4. India Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.3.4.1. Healthcare Providers
14.6.3.4.2. Pharmaceutical & Biotechnology Company
14.6.3.4.3. Patient
14.6.3.4.4.
Payer
14.6.4. Australia
14.6.4.1. Australia Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Component
14.6.4.1.1. Hardware
14.6.4.1.2. Software
14.6.4.1.3. Service
14.6.4.2. Australia Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Technology
14.6.4.2.1. Querying Method
14.6.4.2.2. Natural Language Processing
14.6.4.2.3. Context Aware Processing
14.6.4.2.4. Speech Recognition
14.6.4.2.5. Decision Management
14.6.4.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.4.3. Australia Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.4.3.1. Robot Assisted Surgery
14.6.4.3.2. Virtual Nursing Assistants
14.6.4.3.3. Administrative Workflow Assistance
14.6.4.3.4. Fraud Detection
14.6.4.3.5. Connected Machines
14.6.4.3.6. Clinical Trial
14.6.4.3.7. Preliminary Diagnosis
14.6.4.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.4.4. Australia Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Healthcare Providers
14.6.4.4.2. Pharmaceutical & Biotechnology Company
14.6.4.4.3. Patient
14.6.4.4.4.
Payer
14.6.5. New Zealand
14.6.5.1. New Zealand Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Component
14.6.5.1.1. Hardware
14.6.5.1.2. Software
14.6.5.1.3. Service
14.6.5.2. New Zealand Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Technology
14.6.5.2.1. Querying Method
14.6.5.2.2. Natural Language Processing
14.6.5.2.3. Context Aware Processing
14.6.5.2.4. Speech Recognition
14.6.5.2.5. Decision Management
14.6.5.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.5.3. New Zealand Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.5.3.1. Robot Assisted Surgery
14.6.5.3.2. Virtual Nursing Assistants
14.6.5.3.3. Administrative Workflow Assistance
14.6.5.3.4. Fraud Detection
14.6.5.3.5. Connected Machines
14.6.5.3.6. Clinical Trial
14.6.5.3.7. Preliminary Diagnosis
14.6.5.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.5.4. New Zealand Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Healthcare Providers
14.6.5.4.2. Pharmaceutical & Biotechnology Company
14.6.5.4.3. Patient
14.6.5.4.4. Payer
14.6.6. Southeast Asia
14.6.6.1. Southeast Asia Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
14.6.6.1.1. Hardware
14.6.6.1.2. Software
14.6.6.1.3. Service
14.6.6.2. Southeast Asia Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
14.6.6.2.1. Querying Method
14.6.6.2.2. Natural Language Processing
14.6.6.2.3. Context Aware Processing
14.6.6.2.4. Speech Recognition
14.6.6.2.5. Decision Management
14.6.6.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.6.3. Southeast Asia Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1. Robot Assisted Surgery
14.6.6.3.2. Virtual Nursing Assistants
14.6.6.3.3. Administrative Workflow Assistance
14.6.6.3.4. Fraud Detection
14.6.6.3.5. Connected Machines
14.6.6.3.6. Clinical Trial
14.6.6.3.7. Preliminary Diagnosis
14.6.6.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.6.4. Southeast Asia Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Healthcare Providers
14.6.6.4.2. Pharmaceutical & Biotechnology Company
14.6.6.4.3. Patient
14.6.6.4.4. Payer
14.6.7. Rest of Asia Pacific
14.6.7.1. Rest of Asia Pacific Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Component
14.6.7.1.1. Hardware
14.6.7.1.2. Software
14.6.7.1.3. Service
14.6.7.2. Rest of Asia Pacific Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.7.2.1. Querying Method
14.6.7.2.2. Natural Language Processing
14.6.7.2.3. Context Aware Processing
14.6.7.2.4. Speech Recognition
14.6.7.2.5. Decision Management
14.6.7.2.6. Others (Biometrics, AI Modeling, Etc.)
14.6.7.3. Rest of Asia Pacific Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1. Robot Assisted Surgery
14.6.7.3.2. Virtual Nursing Assistants
14.6.7.3.3. Administrative Workflow Assistance
14.6.7.3.4. Fraud Detection
14.6.7.3.5. Connected Machines
14.6.7.3.6. Clinical Trial
14.6.7.3.7. Preliminary Diagnosis
14.6.7.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
14.6.7.4. Rest of Asia Pacific Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Healthcare Providers
14.6.7.4.2. Pharmaceutical & Biotechnology Company
14.6.7.4.3. Patient
14.6.7.4.4. Payer
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Component
14.7.3. By Technology
14.7.4. By Application
14.7.5. By End Users
15. Middle East and Africa Artificial Intelligence in Medicine
Market Analysis and Forecasts, 2019 – 2027
15.1. Overview
15.1.1. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn)
15.2. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Component
15.2.1. Hardware
15.2.2. Software
15.2.3. Service
15.3. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Querying Method
15.3.2. Natural Language Processing
15.3.3. Context Aware Processing
15.3.4. Speech Recognition
15.3.5. Decision Management
15.3.6. Others (Biometrics, AI Modeling, Etc.)
15.4. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Robot Assisted Surgery
15.4.2. Virtual Nursing Assistants
15.4.3. Administrative Workflow Assistance
15.4.4. Fraud Detection
15.4.5. Connected Machines
15.4.6. Clinical Trial
15.4.7. Preliminary Diagnosis
15.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
15.5. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Healthcare Providers
15.5.2. Pharmaceutical & Biotechnology Company
15.5.3. Patient
15.5.4. Payer
15.6. Middle East and Africa Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. GCC Countries
15.6.1.1. GCC Countries Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
15.6.1.1.1. Hardware
15.6.1.1.2. Software
15.6.1.1.3. Service
15.6.1.2. GCC Countries Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
15.6.1.2.1. Querying Method
15.6.1.2.2. Natural Language Processing
15.6.1.2.3. Context Aware Processing
15.6.1.2.4. Speech Recognition
15.6.1.2.5. Decision Management
15.6.1.2.6. Others (Biometrics, AI Modeling, Etc.)
15.6.1.3. GCC Countries Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1. Robot Assisted Surgery
15.6.1.3.2. Virtual Nursing Assistants
15.6.1.3.3. Administrative Workflow Assistance
15.6.1.3.4. Fraud Detection
15.6.1.3.5. Connected Machines
15.6.1.3.6. Clinical Trial
15.6.1.3.7. Preliminary Diagnosis
15.6.1.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
15.6.1.4. GCC Countries Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Healthcare Providers
15.6.1.4.2. Pharmaceutical & Biotechnology Company
15.6.1.4.3. Patient
15.6.1.4.4. Payer
15.6.2. Southern Africa
15.6.2.1. Southern Africa Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
15.6.2.1.1. Hardware
15.6.2.1.2. Software
15.6.2.1.3. Service
15.6.2.2. Southern Africa Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
15.6.2.2.1. Querying Method
15.6.2.2.2. Natural Language Processing
15.6.2.2.3. Context Aware Processing
15.6.2.2.4. Speech Recognition
15.6.2.2.5. Decision Management
15.6.2.2.6. Others (Biometrics, AI Modeling, Etc.)
15.6.2.3. Southern Africa Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1. Robot Assisted Surgery
15.6.2.3.2. Virtual Nursing Assistants
15.6.2.3.3. Administrative Workflow Assistance
15.6.2.3.4. Fraud Detection
15.6.2.3.5. Connected Machines
15.6.2.3.6. Clinical Trial
15.6.2.3.7. Preliminary Diagnosis
15.6.2.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
15.6.2.4. Southern Africa Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Healthcare Providers
15.6.2.4.2. Pharmaceutical & Biotechnology Company
15.6.2.4.3. Patient
15.6.2.4.4. Payer
15.6.3. Rest of MEA
15.6.3.1. Rest of MEA Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Component
15.6.3.1.1. Hardware
15.6.3.1.2. Software
15.6.3.1.3. Service
15.6.3.2. Rest of MEA Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Technology
15.6.3.2.1. Querying Method
15.6.3.2.2. Natural Language Processing
15.6.3.2.3. Context Aware Processing
15.6.3.2.4. Speech Recognition
15.6.3.2.5. Decision Management
15.6.3.2.6. Others (Biometrics, AI Modeling, Etc.)
15.6.3.3. Rest of MEA Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.3.3.1. Robot Assisted Surgery
15.6.3.3.2. Virtual Nursing Assistants
15.6.3.3.3. Administrative Workflow Assistance
15.6.3.3.4. Fraud Detection
15.6.3.3.5. Connected Machines
15.6.3.3.6. Clinical Trial
15.6.3.3.7. Preliminary Diagnosis
15.6.3.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
15.6.3.4. Rest of MEA Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Healthcare Providers
15.6.3.4.2. Pharmaceutical & Biotechnology Company
15.6.3.4.3. Patient
15.6.3.4.4. Payer
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Component
15.7.3. By Technology
15.7.4. By Application
15.7.5. By End Users
16. Latin America Artificial Intelligence in Medicine Market
Analysis and Forecasts, 2019 – 2027
16.1. Overview
16.1.1. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn)
16.2. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Component
16.2.1. Hardware
16.2.2. Software
16.2.3. Service
16.3. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Technology
16.3.1. Querying Method
16.3.2. Natural Language Processing
16.3.3. Context Aware Processing
16.3.4. Speech Recognition
16.3.5. Decision Management
16.3.6. Others (Biometrics, AI Modeling, Etc.)
16.4. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Robot Assisted Surgery
16.4.2. Virtual Nursing Assistants
16.4.3. Administrative Workflow Assistance
16.4.4. Fraud Detection
16.4.5. Connected Machines
16.4.6. Clinical Trial
16.4.7. Preliminary Diagnosis
16.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
16.5. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Healthcare Providers
16.5.2. Pharmaceutical & Biotechnology Company
16.5.3. Patient
16.5.4. Payer
16.6. Latin America Artificial Intelligence in Medicine Market
Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Component
16.6.1.1.1. Hardware
16.6.1.1.2. Software
16.6.1.1.3. Service
16.6.1.2. Brazil Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Technology
16.6.1.2.1. Querying Method
16.6.1.2.2. Natural Language Processing
16.6.1.2.3. Context Aware Processing
16.6.1.2.4. Speech Recognition
16.6.1.2.5. Decision Management
16.6.1.2.6. Others (Biometrics, AI Modeling, Etc.)
16.6.1.3. Brazil Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By Application
16.6.1.3.1. Robot Assisted Surgery
16.6.1.3.2. Virtual Nursing Assistants
16.6.1.3.3. Administrative Workflow Assistance
16.6.1.3.4. Fraud Detection
16.6.1.3.5. Connected Machines
16.6.1.3.6. Clinical Trial
16.6.1.3.7. Preliminary Diagnosis
16.6.1.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
16.6.1.4. Brazil Artificial Intelligence in Medicine Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.1.4.1. Healthcare Providers
16.6.1.4.2. Pharmaceutical & Biotechnology Company
16.6.1.4.3. Patient
16.6.1.4.4.
Payer
16.6.2. Argentina
16.6.2.1. Argentina Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Component
16.6.2.1.1. Hardware
16.6.2.1.2. Software
16.6.2.1.3. Service
16.6.2.2. Argentina Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Technology
16.6.2.2.1. Querying Method
16.6.2.2.2. Natural Language Processing
16.6.2.2.3. Context Aware Processing
16.6.2.2.4. Speech Recognition
16.6.2.2.5. Decision Management
16.6.2.2.6. Others (Biometrics, AI Modeling, Etc.)
16.6.2.3. Argentina Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By Application
16.6.2.3.1. Robot Assisted Surgery
16.6.2.3.2. Virtual Nursing Assistants
16.6.2.3.3. Administrative Workflow Assistance
16.6.2.3.4. Fraud Detection
16.6.2.3.5. Connected Machines
16.6.2.3.6. Clinical Trial
16.6.2.3.7. Preliminary Diagnosis
16.6.2.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
16.6.2.4. Argentina Artificial Intelligence in Medicine Market Revenue
(US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Healthcare Providers
16.6.2.4.2. Pharmaceutical & Biotechnology Company
16.6.2.4.3. Patient
16.6.2.4.4. Payer
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Component
16.6.3.1.1. Hardware
16.6.3.1.2. Software
16.6.3.1.3. Service
16.6.3.2. Rest of Latin America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.3.2.1. Querying Method
16.6.3.2.2. Natural Language Processing
16.6.3.2.3. Context Aware Processing
16.6.3.2.4. Speech Recognition
16.6.3.2.5. Decision Management
16.6.3.2.6. Others (Biometrics, AI Modeling, Etc.)
16.6.3.3. Rest of Latin America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Robot Assisted Surgery
16.6.3.3.2. Virtual Nursing Assistants
16.6.3.3.3. Administrative Workflow Assistance
16.6.3.3.4. Fraud Detection
16.6.3.3.5. Connected Machines
16.6.3.3.6. Clinical Trial
16.6.3.3.7. Preliminary Diagnosis
16.6.3.3.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)
16.6.3.4. Rest of Latin America Artificial Intelligence in Medicine
Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Healthcare Providers
16.6.3.4.2. Pharmaceutical & Biotechnology Company
16.6.3.4.3. Patient
16.6.3.4.4. Payer
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Component
16.7.3. By Technology
16.7.4. By Application
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Player Positioning Analysis
17.2. Global Presence and Growth Strategies
18. Player Profiles
18.1. Bay Labs, Inc
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. CloudMedx Inc.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Enclitic
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. General Electric
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. General Vision
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Google Inc.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. IBM Corporation
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. iCarbonX
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Intel Corporation
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Koninklijke Philips
18.10.1.
Company Details
18.10.2.
Company Overview
18.10.3.
Product Offerings
18.10.4.
Key Developments
18.10.5.
Financial Analysis
18.10.6.
SWOT Analysis
18.10.7.
Business Strategies
18.11. maxQ
18.11.1.
Company Details
18.11.2.
Company Overview
18.11.3.
Product Offerings
18.11.4.
Key Developments
18.11.5.
Financial Analysis
18.11.6.
SWOT Analysis
18.11.7.
Business Strategies
18.12. Microsoft
18.12.1.
Company Details
18.12.2.
Company Overview
18.12.3.
Product Offerings
18.12.4.
Key Developments
18.12.5.
Financial Analysis
18.12.6.
SWOT Analysis
18.12.7.
Business Strategies
18.13. Next IT Corp.
18.13.1.
Company Details
18.13.2.
Company Overview
18.13.3.
Product Offerings
18.13.4.
Key Developments
18.13.5.
Financial Analysis
18.13.6.
SWOT Analysis
18.13.7.
Business Strategies
18.14. Nvidia Corporation
18.14.1.
Company Details
18.14.2.
Company Overview
18.14.3.
Product Offerings
18.14.4.
Key Developments
18.14.5.
Financial Analysis
18.14.6.
SWOT Analysis
18.14.7.
Business Strategies
18.15. Siemens Healthcare GmbH
18.15.1.
Company Details
18.15.2.
Company Overview
18.15.3.
Product Offerings
18.15.4.
Key Developments
18.15.5.
Financial Analysis
18.15.6.
SWOT Analysis
18.15.7.
Business Strategies
18.16. Welltok
18.16.1. Company Details
18.16.2. Company Overview
18.16.3. Product Offerings
18.16.4. Key Developments
18.16.5.
Financial Analysis
18.16.6.
SWOT Analysis
18.16.7.
Business Strategies
19. Key Findings
Note: This ToC is
tentative and can be changed according to the research study conducted during
the course of report completion.
**Exclusive for Multi-User and
Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.